Senescence of human pancreatic beta cells enhances functional maturation through chromatin reorganization and promotes interferon responsiveness.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
Senescent cells can influence the function of tissues in which they reside, and their propensity for disease. A portion of adult human pancreatic beta cells express the senescence marker p16, yet it is unclear whether they are in a senescent state, and how this affects insulin secretion. We analyzed single-cell transcriptome datasets of adult human beta cells, and found that p16-positive cells express senescence gene signatures, as well as elevated levels of beta-cell maturation genes, consistent with enhanced functionality. Senescent human beta-like cells in culture undergo chromatin reorganization that leads to activation of enhancers regulating functional maturation genes and acquisition of glucose-stimulated insulin secretion capacity. Strikingly, Interferon-stimulated genes are elevated in senescent human beta cells, but genes encoding senescence-associated secretory phenotype (SASP) cytokines are not. Senescent beta cells in culture and in human tissue show elevated levels of cytoplasmic DNA, contributing to their increased interferon responsiveness. Human beta-cell senescence thus involves chromatin-driven upregulation of a functional-maturation program, and increased responsiveness of interferon-stimulated genes, changes that could increase both insulin secretion and immune reactivity.
Description
Funder: Stichting Onderzoek Nederland
Funder: DKFZ; doi: https://doi.org/10.13039/100008658
Funder: Woll Sisters and Brothers Chair in Cardiovascular Diseases
Funder: Walter and Greta Stiel Chair and Research
Keywords
Journal Title
Conference Name
Journal ISSN
1362-4962
Volume Title
Publisher
Publisher DOI
Sponsorship
British Council BIRAX Program (65BX18MNIB)
Juvenile Diabetes Research Fund (3-SRA-2024-1479-S-B)
Ministry of Science, Technology and Space (0004062)
Human Islet Research Network (U01 DK135001, U01 DK134995)
NIDDK (R01 DK133442)
Cancer Research UK (C9545/A29580)